BRENNAN CALDER: Open Payments
NPI 1245712165 · WACO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$776 in 34 payments from 13 companies in 2025. Trend: 2023 $936 · 2024 $1,119 · 2025 $776
Food & beverage: $666Education: $110
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $156 |
| Galderma Laboratories, L.P. | 3 | $103 |
| Janssen Biotech, Inc. | 1 | $100 |
| Regeneron Healthcare Solutions, Inc. | 3 | $74 |
| Amgen Inc. | 3 | $66 |
| UCB, Inc. | 2 | $65 |
| Novartis Pharmaceuticals Corporation | 2 | $45 |
| Incyte Corporation | 2 | $39 |
| GENZYME CORPORATION | 1 | $34 |
| PFIZER INC. | 2 | $33 |
Products named: NEMLUVIO, TREMFYA, SKYRIZI, DUPIXENT, RINVOQ, OTEZLA, Bimzelx, COSENTYX.
Industry payments across TX — which companies pay providers there.
